...
首页> 外文期刊>British Journal of Dermatology >An 18-year retrospective study on the outcomes of keratoacanthomas with different treatment modalities at a single academic centre
【24h】

An 18-year retrospective study on the outcomes of keratoacanthomas with different treatment modalities at a single academic centre

机译:单个学术中心不同治疗方式的角化弧瘤结果为18年的回顾性研究

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Dear Editors, The clinical course for keratoacanthomas (KAs) varies from self-resolving to invasive cancers.1'2 KA is often treated with surgical intervention," but other treatments such as electrodessication and curettage,4 cryotherapy,4 topical medications,2'5 intralesional chemotherapy,2 acitretin2 and active surveillance have been employed. Randomized controlled studies of different treatment modalities are lacking. The largest systematic review consisted of 113 case reports and case series (445 patients included) and reported 18 recurrent or persistent KA cases (4%),2 but this data is prone to publication bias, as unusual cases are more likely to be reported and treatment outcomes could not be directly compared.
机译:亲爱的编辑,Keratoacanthomas(KAS)的临床课程因自我分解而异,以侵入性癌症.1'2 KA经常用手术干预治疗,“其他治疗如电解和刮宫,4个冷冻疗法,4个局部药物,2' 使用5个内部化疗,2个丙酸丁质2和主动监测。缺乏不同治疗方式的随机对照研究。最大的系统审查由113例报告和案例系列(包括445名患者),报告18次复发或持续的KA病例(4 %),2但是这种数据易于出版物偏见,因为更容易报告不寻常的病例,并且不能直接比较治疗结果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号